Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies

Clinical trial NCT04847063 · RECRUITING

Trial details

NCT number: NCT04847063
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Peritoneal Mesothelioma Peritoneal Carcinomatosis Ovarian Cancer Gastrointestinal Cancer Appendiceal Cancer Atypical Mesothelial Proliferation Colorectal Cancer

Start date: 2021-10-19
Primary completion: 2033-12-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.